問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberPOLARIS2009-001

2011-07-01 - 2013-06-30

Phase III

Study ended11

  • Trial Applicant

    PROTECH PHARMASERVICES CORPORATION

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator PEI-JER CHEN Division of General Internal Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator Yee Chao Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator 謝瑞坤 Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator Kuan-Der Lee Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator Chen-Chun Lin Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator 盧勝男 Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator Chia-Jui Yen Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator Li-Tzong Chen Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator 馮盈勳 Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator Shang-Hung Chen Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator 謝瑞坤 Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    120 participants

  • Global

    732 participants